MedRhythms Launches Clinical Trial of Digital Therapeutic in Parkinson s Disease and Expands Pipeline to Aging
News provided by
Share this article
Share this article
PORTLAND, Maine, April 13, 2021 /PRNewswire/ MedRhythms, a digital therapeutics company building direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury, today announced the initiation of a multi-site clinical trial, in collaboration with Boston University and one of the world s leading hospitals, of its pipeline asset MR-005 in Parkinson s disease (PD) as well as the expansion of the company s pipeline into aging with the development of its Aging Scientific Advisory Board (SAB). This follows MedRhythms announcement of the advancement of its pipeline into PD and multiple sclerosis (MS) in 2020 with the initiation of clinical trials and the development of MS and PD SABs.
By Katie Trojano, Reporter Staff
March 4, 2021
Katie Trojano, Reporter Staff
Deanna and Sidney Wolk say their generous gift will help make ‘the Memory Center’ available to anybody who needs it.”
A Dorchester native and his wife have donated $5 million to help those battling dementia and Alzheimer’s under the auspices of the Hebrew SeniorLife Center in Roslindale. The contribution will help the non-profit assist seniors and their caregivers through the newly renamed Deanna and Sidney Wolk Center for Memory Health, an outpatient center next to the Arnold Arboretum that is affiliated with Harvard Medical School.
“We want people to know about the program, to use it. We want to be able to help them in their needs,” said Sidney Wolk, who grew up in a family of modest means near Fields Corner. As a child, he said, he was taught the importance of “tzedakah,” the Hebrew word for charitable giving.
A Better Way to Zap Our Brains
A Better Way to Zap Our Brains
New research suggests that stimulating neurons in the brain can address psychological issues with surprising speed and precision.
Credit.Illustration by Ori Toor
Published Feb. 24, 2021Updated Feb. 25, 2021
The brain is an electrical organ. Everything that goes on in there is a result of millivolts zipping from one neuron to another in particular patterns. This raises the tantalizing possibility that, should we ever decode those patterns, we could electrically adjust them to treat neurological dysfunction from Alzheimer’s to schizophrenia or even optimize desirable qualities like intelligence and resilience.
Unehäired - uue aja epideemia | Unetu tähelepanekud ja soovitused - Alkeemia alkeemia.delfi.ee - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alkeemia.delfi.ee Daily Mail and Mail on Sunday newspapers.